• 5 CBD Oils That Help Insomniacs Catch Shut-eye
    by Staff on July 18, 2018 at 4:00 PM

    By Suzannah Weiss When I began struggling to fall and stay asleep due to a combination of constant travel and late work hours, I tried everything in the book — melatonin (which would wake me up in the middle of the night and leave me groggy in the morning), weed (which put me in a [... […]

  • Study of Delivery Customers Finds Marijuana is Used as Substitute for Prescription Medicines, Painkillers
    by Don Jergler on July 13, 2018 at 12:13 AM

    Many people who get cannabis delivered aren’t just getting high, in fact most are using it to augment or replace prescription drugs, and in some cases wean themselves off addictive painkillers. That’s according to a new study titled “Exploring cannabis use reasons and experiences among mobile cannabis delivery patients” published in June 2018 in the [... […]

  • Another Study Finds Legalized Marijuana Reduces Opioid Prescriptions
    by Jessica Peralta on July 12, 2018 at 7:15 PM

    A study published in  the peer-reviewed journal Addiction adds to a growing body of research finding that opioid prescriptions decline after cannabis is legalized. Researchers from the University of California, San Diego in California and Weill Cornell Medical College in New York on Tuesday, July 10, 2018, published “Medical cannabis legalization and opioid prescriptions: evidence [... […]

  • Australian Study Finds Marijuana is Ineffective Remedy for Chronic Pain
    by Jessica Peralta on July 11, 2018 at 8:20 PM

    A recent study by researchers at the University of New South Wales (UNSW) Sydney challenges the idea that cannabis could be effective for chronic non-cancer pain management. Published in the July 2018 The Lancet Public Health journal, the study, titled “Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a [... […]

  • A Whole-Plant Terpene Profile for Extracts? Israel Company is Making it Happen
    by Don Jergler on July 6, 2018 at 7:15 PM

    Consistency is the path to success for Eybna Technologies Ltd., a developer of custom cannabis extraction methods. The research and development company, founded in 2014 in Israel, specializes in developing what can be considered terpene technology, which is sold to companies in the US, Canada and Europe, mostly through CDB distillates and oils. Its ultimate [... […]

  • Curious About Cannabis? Sativa Science Club is Here to Help
    by Maureen Meehan on June 27, 2018 at 12:30 AM

    Portland’s Sativa Science Club, a serious science and business school, seeks to fill an important need in the cannabis industry: educating people. The first academic program of its kind — independent of any of Oregon’s 510 dispensaries, law offices, and investment companies – it opened its classroom doors in June 2017. And, like the rest of [... […]

  • FDA’s Approval of CBD Epilepsy Drug Draws Praise From Democrats and GOP
    by Monterey Bud on June 26, 2018 at 11:20 PM

    The United States Food and Drug Administration’s approval of Epidiolex, created from CBD, a therapeutic cannabinoid found in marijuana, fired up officials — including the FDA Commissioner — who took to Twitter to share praise and support of this historic approval. “This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients [... […]

  • Physician Aims For High-Tech, Curative Cannabis Medicine in Her Oregon Practice
    by Maureen Meehan on June 26, 2018 at 12:00 AM

    Dr. Janice Knox was the first in her immediate family of four doctors to leave traditional medicine. After 35 years of working as an anesthesiologist, she began researching cannabis therapeutics and endocannabinology, a specialty concerned with the study and treatment of the body’s endocannabinoid system. “How could I be a physician and not be interested [... […]

  • FDA OKs Epidolex, The First Marijuana-Based Pharmaceutical to Treat Epilepsy
    by Associated Press on June 25, 2018 at 6:10 PM

    By Matthew Perrone WASHINGTON (AP) — US health regulators on Monday, June 25, 2018, approved the first prescription drug made from marijuana, a milestone that could spur more research into a drug that remains illegal under federal law, despite growing legalization for recreational and medical use. The Food and Drug Administration approved the medication, called [... […]

  • What’s in a Name? Researcher Finds Inconsistent Qualities Among Marijuana Strains
    by Lauren Williams on June 15, 2018 at 7:00 PM

    Strains by the same name sold at different dispensaries have significant genetic variations that could result in inconsistent physiological effects on consumers, according to recently released research. Doctoral candidate Anna Schwabe, who is studying population and evolutionary genetics at the University of Northern Colorado in Greeley, tested 122 strains of cannabis in Washington, Colorado and [... […]